Tumour-blocking role found for cell regulation molecule

January 9, 2015 by Jamie Brown

Manchester scientists have explored the role of a protein in regulating tumour development and found that it suppresses liver cancer growth in the lab.

In order to develop new anti-cancer treatments, researchers need to identify target molecules that are responsible for controlling tumour growth. Two such molecules are JNK and p38, which both regulate cell multiplication and cell death.

In a new project scientists from the Cancer Research UK Manchester Institute at The University of Manchester – part of the Manchester Cancer Research Centre – have investigated the role of a protein controlled by JNK and p38, known as ATF2, in tumour development.

Professor Nic Jones, leader of the Cell Regulation group and Director of the Manchester Cancer Research Centre, who led the study, said: "There have been conflicting findings in terms of whether JNK and ATF2 suppress or encourage tumour growth. We wanted to clarify their role in the development of cancer."

The researchers investigated a model of liver and demonstrated that ATF2 appeared to suppress . Further study showed that this process was dependent on JNK. They then examined molecules controlled by ATF2 and found that some of them were present in reduced levels in a number of different human tumours compared with normal cells.

This result suggests that ATF2 function is impaired during tumour development and indicates that its tumour suppression role may be more widespread than just .

"We have demonstrated that JNK and ATF2 have a to play in tumour suppression. Additional research is now needed to determine what causes changes in the levels of these ATF2-dependent molecules in tumours," added Professor Jones.

Explore further: Further evidence of potential for new anti-cancer drug

More information: Paper entitled 'JNK suppresses tumour formation via a gene expression programme mediated by ATF2' Gozdecka et al. (2014) Cell Reports. 2014 Nov 20;9(4):1361-74. DOI: 10.1016/j.celrep.2014.10.043.

Related Stories

Further evidence of potential for new anti-cancer drug

November 6, 2014

(Medical Xpress)—Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy – suggesting a new approach that could ...

New tool to probe cancer's molecular make-up

August 26, 2014

Scientists have shown how to better identify and measure vital molecules that control cell behaviour – paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

Carcinogenic role of a protein in liver decoded

September 1, 2014

The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study group at the Comprehensive ...

Recommended for you

Psychological science explores the minds of dogs

October 24, 2016

Dogs are one of the most common household pets in the world, so it's curious that we know relatively little about their cognitive abilities when we know so much about the abilities of other animals, from primates to cetaceans. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.